These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 16690812)

  • 1. Epigenetics, evolution, endocrine disruption, health, and disease.
    Crews D; McLachlan JA
    Endocrinology; 2006 Jun; 147(6 Suppl):S4-10. PubMed ID: 16690812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Epigenetics in the Latent Effects of Early Life Exposure to Obesogenic Endocrine Disrupting Chemicals.
    Stel J; Legler J
    Endocrinology; 2015 Oct; 156(10):3466-72. PubMed ID: 26241072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenerational epigenetic effects from male exposure to endocrine-disrupting compounds: a systematic review on research in mammals.
    Van Cauwenbergh O; Di Serafino A; Tytgat J; Soubry A
    Clin Epigenetics; 2020 May; 12(1):65. PubMed ID: 32398147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesogens: an emerging threat to public health.
    Janesick AS; Blumberg B
    Am J Obstet Gynecol; 2016 May; 214(5):559-65. PubMed ID: 26829510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental factors, epigenetics, and developmental origin of reproductive disorders.
    Ho SM; Cheong A; Adgent MA; Veevers J; Suen AA; Tam NNC; Leung YK; Jefferson WN; Williams CJ
    Reprod Toxicol; 2017 Mar; 68():85-104. PubMed ID: 27421580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In utero exposure to endocrine-disrupting chemicals, maternal factors and alterations in the epigenetic landscape underlying later-life health effects.
    Lite C; Raja GL; Juliet M; Sridhar VV; Subhashree KD; Kumar P; Chakraborty P; Arockiaraj J
    Environ Toxicol Pharmacol; 2022 Jan; 89():103779. PubMed ID: 34843942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenerational epigenetic imprints on mate preference.
    Crews D; Gore AC; Hsu TS; Dangleben NL; Spinetta M; Schallert T; Anway MD; Skinner MK
    Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5942-6. PubMed ID: 17389367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory effects of environmental endocrine disrupting chemicals.
    Kuo CH; Yang SN; Kuo PL; Hung CH
    Kaohsiung J Med Sci; 2012 Jul; 28(7 Suppl):S37-42. PubMed ID: 22871600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental epigenomics: Current approaches to assess epigenetic effects of endocrine disrupting compounds (EDC's) on human health.
    Tapia-Orozco N; Santiago-Toledo G; Barrón V; Espinosa-García AM; García-García JA; García-Arrazola R
    Environ Toxicol Pharmacol; 2017 Apr; 51():94-99. PubMed ID: 28215500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenerational effects of obesogens and the obesity epidemic.
    Chamorro-García R; Blumberg B
    Curr Opin Pharmacol; 2014 Dec; 19():153-8. PubMed ID: 25460228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parental effects of endocrine disrupting compounds in aquatic wildlife: Is there evidence of transgenerational inheritance?
    Schwindt AR
    Gen Comp Endocrinol; 2015 Aug; 219():152-64. PubMed ID: 25639828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding Epigenetic Effects of Endocrine Disrupting Chemicals: From Mechanisms to Novel Test Methods.
    Alavian-Ghavanini A; Rüegg J
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):38-45. PubMed ID: 28842957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine disrupting chemicals: human exposure and health risks.
    Yang M; Park MS; Lee HS
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2006; 24(2):183-224. PubMed ID: 17114110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences.
    Fenton SE
    Endocrinology; 2006 Jun; 147(6 Suppl):S18-24. PubMed ID: 16690811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine disrupters and female reproductive health.
    McLachlan JA; Simpson E; Martin M
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):63-75. PubMed ID: 16522520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine impacts of endocrine-disrupting chemicals in birds: life stage and species sensitivities.
    Ottinger MA; Dean KM
    J Toxicol Environ Health B Crit Rev; 2011; 14(5-7):413-22. PubMed ID: 21790319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key developments in endocrine disrupter research and human health.
    Phillips KP; Foster WG
    J Toxicol Environ Health B Crit Rev; 2008 Mar; 11(3-4):322-44. PubMed ID: 18368559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to the environmental endocrine disruptor TCDD and human reproductive dysfunction: Translating lessons from murine models.
    Bruner-Tran KL; Gnecco J; Ding T; Glore DR; Pensabene V; Osteen KG
    Reprod Toxicol; 2017 Mar; 68():59-71. PubMed ID: 27423904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of endocrine disruptors on growth and development of children.
    DiVall SA
    Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):50-5. PubMed ID: 23222850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prenatal exposure to endocrine disruptors and toxic metals on the fetal epigenome.
    Bommarito PA; Martin E; Fry RC
    Epigenomics; 2017 Mar; 9(3):333-350. PubMed ID: 28234024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.